Table 1.
Parameters |
Phases of the trial |
|||
---|---|---|---|---|
B | T2 | T4 | W | |
Weight (kg) | 56.2 ± 7.1 | 56.2 ± 6.1 | 55.6 ± 6.1 | 55.9 ± 5.9 |
Systolic blood pressure (mmHg) | 116.1 ± 10.3 | 110.3 ± 14.5 | 110.7 ± 15.5 | 107.7 ± 13.2 |
Diastolic blood pressure (mmHg) | 68.2 ± 9.4 | 64.5 ± 14.0 | 63.6 ± 11.7 | 59.5 ± 9.1 |
Heart rate at rest (beats/min) | 65.9 ± 10.7 | 67.2 ± 10.9 | 66.6 ± 8.2 | 68.7 ± 9.9 |
ALT (IU/L) | 7.3 ± 1.0 | 6.8 ± 1.4 | 8.4 ± 1.6 | 7.6 ± 1.5 |
AST (IU/L) | 8.1 ± 1.1 | 10.0 ± 2.0 | 10.6 ± 1.8* | 9.8 ± 1.2 |
Fasting glucose levelsa (mM) | 4.31 ± 1.18 | 4.60 ± 0.92 | 4.21 ± 1.54 | --- |
Postprandial glucose levelsa (mM) | 5.33 ± 1.64 | 4.35 ± 0.53 | 4.88 ± 0.94 | 4.58 ± 0.90 |
Values are mean ± SEM (n = 6).
P ≤ 0.05 when compared with baseline values.
Glucose concentration in blood.